[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
Status:
Active, not recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
In this study, positron emission tomography (PET/CT) imaging will be used to evaluate sigma-2
(σ2) receptor activity in sites of primary breast cancer using the investigational
radiotracer [18F]ISO-1.
Phase:
Phase 1
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania University of Pennsylvania